IMPACT THERAP-B (07630.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 11.37

From 52W high−69.41%

Volume21.16M

Market capHKD 3.60B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 11.37

From 52W high

−69.41%

Volume

21.16M

Market cap

HKD 3.60B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

48.1

MomentumView details →

1D Return

+15.51%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

87.17%

Net Margin

−214.26%

EBITDA Margin

−169.94%

ROE (TTM)

−32.13%

ROA (TTM)

−21.59%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

+396.49%

EPS YoY

+20.04%

FCF YoY

−42.11%

Revenue CAGR 3Y

−59.98%

EPS CAGR 3Y

+16.67%

EBITDA YoY

−10.40%

MomentumView details →

1D Return

+15.51%

YTD Return

—

1Y Return

—

RSI (14)

48.1

vs 50D SMA

−1.62%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

8.06x

Quick Ratio

7.89x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.05

EPS Surprise

−48.03%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

−48.03%

Rev Surprise

−89.27%

Financials snapshotView financials →

Revenue (TTM)

20.60M

Net Income (TTM)

−72.75M

Op. CF (TTM)

−23.66M

Next earningsMar 3, 2027 →

Latest newsMore news →

Impac Pharma issued a profit warning on August 11, 2026, expecting H1 2026 revenue of approximately 94.7 million to 116 million yuan, up 276%-359% year-on-year, and a net loss of 81.7 million to 99.9 million yuan, narrowing 22%-37% from the prior year.40d ago

Similar companies

Organon & Co.OGN Tong Ren Tang Technologies Co. Ltd.01666.HK Grifols, S.A.GRFS 神奇制药600613.SH 天目药业600671.SH 广誉远600771.SH Find similar companies →

Latest newsMore news →

Impac Pharma issued a profit warning on August 11, 2026, expecting H1 2026 revenue of approximately 94.7 million to 116 million yuan, up 276%-359% year-on-year, and a net loss of 81.7 million to 99.9 million yuan, narrowing 22%-37% from the prior year.40d ago